Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.
<h4>Background</h4>Evaluation of cystic fibrosis transmembrane conductance regulator (CFTR) functional activity to assess new therapies and define diagnosis of cystic fibrosis (CF) is cumbersome. It is known that leukocytes express detectable levels of CFTR but the molecule has not been...
Main Authors: | Claudio Sorio, Mario Buffelli, Chiara Angiari, Michele Ettorre, Jan Johansson, Marzia Vezzalini, Laura Viviani, Mario Ricciardi, Genny Verzè, Baroukh Maurice Assael, Paola Melotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21811577/?tool=EBI |
Similar Items
-
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
by: Katherine B. Hisert, et al.
Published: (2020-08-01) -
Blood monocytes in cystic fibrosis
by: Rao, Satish Ramakrishna
Published: (2009) -
Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.
by: Paola Melotti, et al.
Published: (2014-01-01) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01) -
The GCC repeat length in the 5'UTR of <it>MRP1 </it>gene is polymorphic: a functional characterization of its relevance for cystic fibrosis
by: Assael Baroukh M, et al.
Published: (2006-02-01)